Australia markets open in 6 hours 37 minutes

Neuren Pharmaceuticals Limited (NEU.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
18.85-0.45 (-2.33%)
At close: 04:10PM AEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
-
231,925
14,553
-
-
Gross profit
-
231,925
14,553
-
-
Operating expenses
Research development
19,191
26,751
12,712
9,516
7,763
Selling general and administrative
4,404
5,946
3,437
1,914
1,763
Total operating expenses
23,607
32,714
16,159
11,438
9,532
Operating income or loss
53,872
199,211
-1,606
-11,438
-9,532
Total other income/expenses net
1,956
225
1,389
3,595
186
Income before tax
56,860
205,140
184
-7,794
-9,193
Income tax expense
1,817
48,059
0
0
0
Income from continuing operations
55,043
157,081
184
-7,794
-9,193
Net income
55,043
157,081
184
-7,794
-9,193
Net income available to common shareholders
55,043
157,081
184
-7,794
-9,193
Basic EPS
0.44
1.24
0.00
-0.07
-0.09
Diluted EPS
0.44
1.20
0.00
-0.07
-0.09
Basic average shares
126,266
127,070
125,966
117,770
107,057
Diluted average shares
126,266
130,792
125,966
117,770
107,057